Annual stroke incidence documented in the MENA region ranged from 27.5 to 63 per 100 000 people, with ischemic stroke subtype being the commonest of all stroke incidences.[@b1-asm-4-387],[@b2-asm-4-387] It is acknowledged that there is scarcity of stroke data in this region, and further studies, both epidemiologic and intervention in nature, are needed to understand if the course of stroke in this specific region is the same or different from its counterparts in the developed world. In the GCC alone, there is evidence pointing to the severe lack of awareness about stroke in the general population, with the highest risk group having the poorest knowledge. [@b3-asm-4-387] The lack of proper knowledge, coupled with an increasingly modernized but unhealthy lifestyle secondary to industrialization, can only exacerbate the already increasing prevalence of chronic, noncommunicable diseases among the Gulf Cooperation Council (GCC) nations and can potentially overwhelm the health sector in the near future if no intervention is done.[@b4-asm-4-387],[@b5-asm-4-387]

In Saudi Arabia, the status of acute stroke care is way behind other developing nations, with only 1 active stroke center out of 7 centers in more than 350 hospitals across the kingdom.[@b6-asm-4-387] Furthermore, data on stroke are insufficient, which may probably explain why there is an equally lack of response from health policy makers. In this retrospective study performed in a tertiary hospital, we aim to describe the clinical profile of Saudi stroke patients who had congestive heart failure (CHF), also an under-studied population, to fill some missing gaps in the current management of stroke and also to add up in the evidence of emerging diseases in the kingdom.

PATIENTS AND METHODS
====================

This is a retrospective chart review study conducted at King Abdullaziz Medical City (KAMC), Riyadh. Records of all Saudi patients admitted at KAMC from 2002--2008 who were diagnosed with heart failure (with or without stroke) based on echocardiogram and/or catheter and with available imaging evidence (CT scan, MRI) were included for review. The records of patients seen at the out-patient department of internal medicine from 2002--2008 were also reviewed for possible patient inclusion. Patients who had other comorbidities such as end-stage organ failure, risk factors for stroke (bleeding disorders, hypercoagulable states, and carotid stenosis) were excluded. All information, including demographics, HF characteristics (ejection fraction \[EF\], medications taken, etc.), stroke risk factors (presence of diabetes mellitus, hypertension, smoking history, and prior myocardial infarction), and metabolic parameters, such as hemoglobin, fasting glucose, lipid (triglycerides, HDL-, LDL-, and total cholesterol), and renal profile (including blood urea nitrogen \[BUN\] and creatinine), as well as electrolytes (Na and K), were recorded. Information also included functional classification of heart failure based on the recommendations of the New York Heart Association (NYHA).[@b7-asm-4-387] All in all, a total of 293 patients (151 males, 142 females) were deemed eligible for the study.

Data analysis
-------------

Data was analyzed using the SPSS, version 16.5 (Chicago, IL, USA). Frequencies were presented as percentage (%) and continuous variables were presented as mean (standard deviation). For group and subgroup comparisons, chi-square test was done for frequencies, independent *t* test for normally distributed continuous variables, and Mann-Whitney U test for variables with non-Gaussian distribution. Significance set at *P*\<.05.

RESULTS
=======

Based on the NYHA classification scheme, 25 patients (8.5%) were under class 1, 50 patients (17.1%) under class 2, 160 patients (54.6%) under class 3, and 58 patients (19.8 %) under class 4 (not shown in [Table 1](#t1-asm-4-387){ref-type="table"}). [Table 1](#t1-asm-4-387){ref-type="table"} describes the general characteristics of the cohort. Out of the 293 eligible charts reviewed, 69 subjects (30.8%) had sub-sequent stroke. Those who had stroke were compared to those without, and found no significant differences in terms of demographics, heart failure characteristics, and stroke risk factors. However, when the 2 groups were compared in terms of metabolic parameters, it was found out that those who had subsequent stroke had borderline significance and higher circulating levels of total cholesterol (*P*=.05) and significantly higher levels of LDL-cholesterol (*P*=.03) as compared to those without. [Table 2](#t2-asm-4-387){ref-type="table"} shows the uniformity of findings done on stroke in Saudi Arabia from 1991 to the present study, in terms of major risk factors (hypertension and diabetes mellitus) and type of stroke (ischemic).

To further dissect these findings, the cohort was sub-divided into males and females, and repeated metabolic comparisons were made while adjusting for age ([Table 3](#t3-asm-4-387){ref-type="table"}). The elevated circulating levels of LDL- and total cholesterol were found in female HF patients (*P* values .02 and .028, respectively), and this significance was absent in the male group. In the males on the other hand, BUN was significantly higher in the stroke group as compared to those without stroke (*P*\<.04). The rest of the parameters in both genders, including glucose, other lipid parameters, renal profile markers, and electrolytes, were comparable. Furthermore, there were no apparent gender differences in terms of HF characteristics and stroke risk factors (not shown in [Table 3](#t3-asm-4-387){ref-type="table"}).

[Figure 1](#f1-asm-4-387){ref-type="fig"} shows that more than half of the patients who had stroke were classified under NYHA class 3 (56.5%), with NYHA class 1 being the least (7.2%). [Figure 2](#f2-asm-4-387){ref-type="fig"} shows that all patients who had stroke occurred in the anterior circulation, with only 5.6% patients having stroke both in the anterior and posterior circulation.

DISCUSSION
==========

In the present study, there was a high prevalence of associated comorbidities among the cohort, which include hypertension, diabetes mellitus, and dyslipidemia. While these diseases are age-related, it is worthy to note that these chronic noncommunicable diseases are very high in the Kingdom,[@b4-asm-4-387] and dyslipidemia alone is extremely high in the general Saudi population, including both children and adults.[@b8-asm-4-387],[@b9-asm-4-387] The highlights of the present study reveal gender differences in the metabolic profile of stroke among Saudi patients with heart failure, atherogenic dyslipidemia being more prominent in females and renal insufficiency more prominent in males, a finding not established in other studies of the same ethnicity. Gender differences in stroke presentation have nevertheless been demonstrated in the Caucasian populations of European and American descent and to a small extent in the Chinese population. [@b10-asm-4-387]--[@b14-asm-4-387] The evidence reveal that chronic atherogenic dyslipidemia increases the predisposition of developing early recurrent stroke in patients who already had a transient ischemic attack,[@b15-asm-4-387] and major adverse cardiovascular events among patients already known to harbor coronary artery disease.[@b16-asm-4-387] The female gender has a better metabolic profile during adolescent and premenopausal stages compared to males,[@b17-asm-4-387] but in the absence of menstruation (menopause), women tend to catch up men in acquiring cardiovascular risk factors, and have an even higher mortality as compared to men in the presence of diabetes mellitus.[@b18-asm-4-387] In the present study, women outnumbered men in encountering stroke (37 versus 32), and while both genders had an abnormal lipid profile, women had worse levels of both LDL- and total cholesterol.

Another gender difference elicited in the present study was the higher circulating levels of BUN among men who had subsequent stroke, a finding not observed among females. It is already known that BUN is a potentially powerful predictor of mortality in patients with acutely decompensated HF.[@b11-asm-4-387],[@b19-asm-4-387] The underlying renal insufficiency can also explain why patients having normal ventricular EFs with diastolic dysfunction develop CHF.[@b20-asm-4-387] On the relationship between renal function and stroke, it has been observed that BUN/creatinine ratio above 15 is an independent predictor of an acute ischemic stroke.[@b21-asm-4-387] The estimated glomerular filtration rate, however, is also a strong predictor for acute stroke, but it is more common and presents a poorer outcome in patients with hemorrhagic, rather than ischemic stroke.[@b22-asm-4-387] The gender difference elicited in this study needs further examination.

Other results in the present study were in accordance with other findings.[@b23-asm-4-387]--[@b27-asm-4-387] There was no significant gender difference in HF medications given to patients, similar to the EuroHeart Failure Survey II 28, and while in the previous study they found a higher proportion of women having diabetes mellitus, this was not the case in the present study, probably secondary to the unequal distribution of subjects. Results from previous local studies also confirm present findings, as shown in ([Table 3](#t3-asm-4-387){ref-type="table"}), with ischemic stroke being the most common type and hypertension and diabetes mellitus the most common risk factors. Worthy to note is the higher mean age of stroke presentation in the present study as compared to other studies, which could either mean improved health care over the past years, or by chance. This needs further confirmation.

The authors acknowledge several study limitations. The findings cannot be generalized for the entire population as it is a single-center study. A larger epidemiologic study is needed to confirm the findings. Furthermore, the retrospective data was limited as it did not include potential confounders such as diet and physical activity. Nevertheless, the strength of the study is its relative large sample size, and that the findings are unique, and the first to demonstrate gender differences in the presentation of Saudi HF patients with subsequent stroke.

In conclusion, the results of the present study suggest gender differences in the metabolic characteristics of Saudi HF patients with subsequent stroke on equal HF medications and stroke risk factors. While standard care is to be routinely given, a more customized approach is recommended in the overall management of these patients, paying closer attention to rehydration status and atherogenic dyslipidemic profile as early warning signs to a possible stroke in males and females, respectively.
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###### 

General characteristics and risk factors among HF patients with and without subsequent stroke.

                                                                       Without stroke   With stroke     *P* value
  -------------------------------------------------------------------- ---------------- --------------- -----------
  Demographics                                                                                          
   N                                                                   224              69              
   Gender (M/F)                                                        119/105          32/37           
   Age (y)                                                             67.6 (12.7)      70.8 (11.9)     .07
  HF characteristics                                                                                    
   Systolic dysfunction (EF \< 55%)                                    167 (74.6)       49 (71)         .64
   Diastolic dysfunction (EF ≥55%)                                     57 (25.4)        20 (29)         .75
   Documented CAD                                                      156 (69.6)       53 (76.8)       .29
   Aspirin                                                             142 (63.4)       38 (55.1)       .26
   Warfarin                                                            41 (18.3)        8 (11.6)        .27
   β-blocker                                                           140 (62.5)       44 (63.8)       .89
   ACE Inhibitor                                                       112 (50.0)       40 (58.0)       .27
  Stroke risk factors                                                                                   
   Diabetes mellitus                                                   107 (47.8)       41 (59.4)       .10
   AF                                                                  46 (20.5)        20 (29.0)       .19
   Prior MI                                                            54 (24.1)        10 (14.5)       .098
   Hypertension                                                        188 (83.9)       61 (88.4)       .44
   Smoking                                                             36 (16.1)        10 (14.5)       .85
  Metabolic parameters                                                                                  
   Glucose (mmol/L)                                                    10.2 (5.5)       10.8 (5.6)      .39
   Triglycerides (mmol/L)                                              1.6 ( 0.7)       1.7 ( 0.8)      .91
   Total cholesterol (mmol/L)                                          3.6 (1.1)        3.9 (1.3)       .05
   HDL-cholesterol (mmol/L)                                            0.94 ( 0.3)      0.98 ( 0.3)     .29
   LDL-cholesterol (mmol/L)[a](#tfn2-asm-4-387){ref-type="table-fn"}   2.3 ( 0.9)       2.6 ( 0.9)      .03
   BUN (g/dL)                                                          12.8 (9.5)       14.1 (8.6)      .31
   Creatinine (mg/dL)                                                  148.9 (123.6)    152.6 (129.7)   .83
   K (mmol/L)                                                          4.3 ( 0.7)       4.3 ( 0.6)      .51
   Na (mmol/L)                                                         135.9(11.2)      136.4 (7.3)     .76
   Hb (g/L)                                                            117.4 (23.1)     111.7 25.5)     .08

BUN: Blood urea nitrogen, K: potassium, Na: sodium, Hb: hemoglobin, LDL: low-density lipoprotein, HDL: high-density lipoprotein, HF: heart failure, AF: atrial fibrillation, CAD: coronary artery disease, ACE: angiotensin-converting enzyme, MI: myocardial infarction, EF: Ejection fraction. Note: Data presented as frequency (%).

Continuous variable, presented as mean (SD); significant *P*\<.05.

###### 

Stroke observational studies in Saudi Arabia (1991--2012).

  Study                  N     Age            Major risk factor   Type
  ---------------------- ----- -------------- ------------------- ----------
  Al-Rajeh et al, 1991   372   \-\-\--        Hypertension        Ischemic
  Al-Rajeh et al, 1993   500   63 (17.0)      Hypertension        Ischemic
  El Sayed et al, 1999   329   62.8 (11.1)    Hypertension + DM   Ischemic
  Qari, 2000             71    63.0           Hypertension        Ischemic
  Present study, 2012    293   70.8 ( 11.9)   Hypertension + DM   Ischemic

DM: Diabetes mellitus.

###### 

Metabolic characteristics of male and female HF patients with and without subsequent stroke.

                               Males           Females                         
  ---------------------------- --------------- --------------- --------------- ----------------
  N                            119             32              105             37
  Age (y)                      65.6 (12.9)     71.7 (12.8)     69.8 (12.0)     69.9 (11.3)
  Glucose (mmol/L)             9.8 ( 5.5)      10.8 ( 5.5)     10.6 (5.5)      10.9 (5.7)
  Triglycerides (mmol/L)       1.6 ( 0.7)      1.4 ( 0.6)      1.6 (0.7)       1.8 (0.8)
  Total cholesterol (mmol/L)   3.4 ( 0.9)      3.4 (1.1)       3.8 (1.2)       4.3 (1.3) ^\*^
  HDL-cholesterol (mmol/L)     0.9 ( 0.3)      ( 0.2)          0.98 (0.3)      (0.3)
  LDL-cholesterol (mmol/L)     2.2 ( 0.8)      2.3 ( 0.9)      2.4 (1.0)       2.8 (0.9) ^\*^
  BUN (g/dL)                   12.2 ( 9.1)     15.5 ( 8.7)a    13.4 (9.9)      12.9 (8.6)
  Creatinine (mg/dL)           158.3 (139.0)   169.7 (120.0)   138.1 (102.8)   137.8 (137.4)
  K (mmol/L)                   4.4 ( 0.7)      4.3 ( 0.6)      4.3 (0.8)       4.3 (0.7)
  Na (mmol/L)                  135.7 (6.8)     136.8 (7.4)     136.1 (14.7)    136.0 (7.3)
  Hb (g/L)                     123.2 (24.8)    114.9 (28.6)    111.0 (19.3)    108.9 (22.4)

BUN: Blood urea nitrogen, K: potassium, Na: sodium, Hb: hemoglobin, LDL: low-density lipoprotein, HDL: high-density lipoprotein, HF: heart failure, AF: atrial fibrillation.
